Oncocyte Appoints Andrea James as Chief Financial Officer
IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it […]
SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on global health and […]
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating […]
Vaxart Provides Business Update
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up […]
Complete Solaria Raises $10 Million in Convertible Debenture to Pay Off Carlyle Debt
LEHI, Utah, June 17, 2024 (GLOBE NEWSWIRE) — Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR), a leading […]
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer […]
PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy
SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company […]
TPI Composites Announces Agreement to Divest Automotive Business Unit as a Part of Continued Focus on Wind
SCOTTSDALE, Ariz., June 17, 2024 (GLOBE NEWSWIRE) — TPI Composites, Inc., (TPI) (Nasdaq: TPIC) announced it has entered into a […]
Credit Acceptance Announces Extension of Revolving Secured Line of Credit Facility
Southfield, Michigan, June 17, 2024 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, […]
Keros Therapeutics Announces Leadership Updates
LEXINGTON, Mass., June 17, 2024 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company […]
